Want to see AU:IBX full AI Analyst Report?
Imagion Biosystems Ltd. (IBX) Stock Statistics & Valuation Metrics
Total Valuation
Imagion Biosystems Ltd. has a market cap or net worth of AUD 4.01M. The enterprise value is AUD 7.55M.
- Market Cap
- AUD 4.01M
- Enterprise Value
- AUD 7.55M
Share Statistics
Imagion Biosystems Ltd. has 801,006,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 801,006,900
- Owned by Insiders
- 2.15%
- Owned by Institutions
- ―
Financial Efficiency
Imagion Biosystems Ltd.’s return on equity (ROE) is 1.99 and return on invested capital (ROIC) is -882.39%.
- Return on Equity (ROE)
- 1.99
- Return on Assets (ROA)
- -2.11
- Return on Invested Capital (ROIC)
- -882.39%
- Return on Capital Employed (ROCE)
- 1.66
- Revenue Per Employee
- 0
- Profits Per Employee
- -391.77K
- Employee Count
- 11
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Imagion Biosystems Ltd. is -0.49. Imagion Biosystems Ltd.’s PEG ratio is -0.01.
- PE Ratio
- -0.49
- PS Ratio
- 0.00
- PB Ratio
- -0.79
- Price to FCF
- -0.73
- Price to Operating Cash Flow
- -0.67
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Imagion Biosystems Ltd. had revenue of 0 and earned -4.31M in profits. Earnings per share was -0.02.
- Revenue
- 0
- Gross Profit
- -8,808
- Operating Income
- -3.58M
- Pretax Income
- -4.35M
- Net Income
- -4.31M
- EBITDA
- -3.58M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -4.05M and capital expenditures 4, giving a free cash flow of -4.05M billion.
- Operating Cash Flow
- -4.05M
- Free Cash Flow
- -4.05M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Imagion Biosystems Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -150.11%
- Earnings Yield
- -188.76%
Stock Price Statistics
- Beta
- 1.55
- 52-Week Price Change
- -37.50%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 1.27M
Important Dates
Imagion Biosystems Ltd. upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 24, 2026
- Next Earnings Date
- Feb 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Imagion Biosystems Ltd. as a current ratio of 0.48, with Debt / Equity ratio of -118.62%
- Current Ratio
- 0.48
- Quick Ratio
- 0.48
- Debt to Market Cap
- 0.36
- Net Debt to EBITDA
- -0.20
- Interest Coverage Ratio
- -4.23
Taxes
In the past 12 months, Imagion Biosystems Ltd. has paid -40.66K in taxes.
- Income Tax
- -40.66K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Imagion Biosystems Ltd. EV to EBITDA ratio is -1.04, with an EV/FCF ratio of -1.20.
- EV to Sales
- 0.00
- EV to EBITDA
- -1.04
- EV to Free Cash Flow
- -1.20
- EV to Operating Cash Flow
- -1.20
Balance Sheet
Imagion Biosystems Ltd. has AUD 32.46K in cash and marketable securities with AUD 2.19M in debt, giving a net cash position of -AUD 2.16M billion.
- Cash & Marketable Securities
- AUD 32.46K
- Total Debt
- AUD 2.19M
- Net Cash
- -AUD 2.16M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- -AUD 0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Imagion Biosystems Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- -3.67%
Scores
- Smart Score
- 9
- AI Score
- 40
